Pharmaceutical compositions, their preparation methods and applications

By using a drug composition of fresh pig placenta and specific Chinese herbal ingredients, the problems of postpartum agalactia or hypogalactia and mastitis in sows were solved, achieving the dual effects of promoting lactation and preventing mastitis, reducing production costs and improving sows' feed intake efficiency and immunity.

CN118319993BActive Publication Date: 2024-11-12SHENZHEN AIZHUZHU TECH GRP CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410277432.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-12
Publication Date
2024-11-12
Estimated Expiration
2044-03-12

AI Technical Summary

Technical Problem

Sows are prone to agalactia or hypogalactia after farrowing, and existing traditional Chinese medicine preparations and antibiotics are ineffective in promoting lactation and have problems such as poor palatability or high cost.

Method used

A pharmaceutical composition comprising fresh pig placenta, astragalus, codonopsis, rehmannia, pangolin scales, vaccaria segetalis, tetrapanax papyriferus, leonurus japonicus, and licorice, as well as excipients soybean and brown sugar, is prepared by a specific method for use in promoting lactation and preventing mastitis.

Benefits of technology

It improves sows' feed intake efficiency, enhances their immunity and milk production, effectively prevents mastitis, reduces production costs, and improves the palatability of the drug composition.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004736362340000111
    Figure BDA0004736362340000111
  • Figure BDA0004736362340000121
    Figure BDA0004736362340000121
Patent Text Reader

Abstract

The present invention relates to a pharmaceutical composition for promoting lactation and preventing mastitis, and a preparation method and application thereof. The pharmaceutical composition comprises 14.9 to 42 parts of placenta, 2 to 4 parts of Chinese medicinal components and 8.9 to 15 parts of auxiliary materials; the Chinese medicinal components include astragalus, codonopsis, rehmannia, pangolin, fenugreek, tongcao, motherwort and liquorice; and the auxiliary materials include soybean and brown sugar. The pharmaceutical composition of the present application utilizes the rational compatibility of placenta with a variety of Chinese medicinal components and auxiliary materials, effectively utilizes the immune substances, proteins and other nutrients in the placenta, and also improves the feeding efficiency of sows, thereby achieving the dual effects of promoting lactation and preventing mastitis. The preparation method of the pharmaceutical composition of the present application is simple and easy to operate, can be completed without the aid of large-scale equipment, and is economical and practical; and in the preparation process, by adding brown sugar twice, the palatability of the pharmaceutical composition is further improved, and the effectiveness of the pharmaceutical composition is greatly improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of aquaculture technology, and in particular to a pharmaceutical composition and a preparation method and application thereof. Background Art

[0002] In the early stage after farrowing, sows usually have less milk or even no milk, which is usually accompanied by mastitis, endometritis and other diseases, which not only affect the health of the sows, but also affect the growth of the piglets and even the survival rate of the piglets. It will further affect the economic benefits of the farm. Traditionally, Chinese medicine or antibiotics are used in the industry, but the former is not easily accepted by sows due to its special smell and poor palatability; the latter can only solve the problem of secondary infection, but cannot achieve the effect of promoting lactation. Summary of the invention

[0003] Based on this, the first object of the present invention is to provide a pharmaceutical composition for promoting lactation and preventing mastitis, the pharmaceutical composition comprising 14.9 to 42 parts of placenta, 2 to 4 parts of traditional Chinese medicine components and 8.9 to 15 parts of auxiliary materials;

[0004] The Chinese medicinal ingredients include astragalus, codonopsis, rehmannia, pangolin, fenugreek, tongcao, motherwort and liquorice;

[0005] Accessories include soybeans and brown sugar.

[0006] In some embodiments, the weight ratio of each ingredient in the traditional Chinese medicine composition is (2-4): (2-4): (1.2-2.4): (2-4): (2-4): (1.2-2.4): (2-4): (1.2-2.4): (2-4): (1-2).

[0007] In some embodiments, the weight ratio of soybeans to brown sugar in the auxiliary material is 1:(1-3).

[0008] In some embodiments, the placenta is a porcine placenta, preferably a fresh porcine placenta.

[0009] The second object of the present invention is to provide a method for preparing the pharmaceutical composition of the present application, comprising the following steps:

[0010] Soak soybeans to obtain a mixture;

[0011] After soaking the Chinese medicinal components, boiling and filtering to obtain a first filter residue and a first filtrate;

[0012] The placenta is mixed with the first brown sugar and marinated, and then boiled with the mixture and filtered to obtain a second residue and a second filtrate;

[0013] The second filter residue is mixed with the codonopsis pilosula, rehmannia glutinosa and liquorice in the first filter residue to obtain a slurry;

[0014] Mixing the first filtrate, the second filtrate and the second brown sugar to obtain a mixed solution; and

[0015] The slurry is mixed with the mixed liquid to obtain a pharmaceutical composition.

[0016] In some embodiments, the soybeans are fried and then soaked.

[0017] In some embodiments, the first brown sugar and the second brown sugar have the same weight.

[0018] In some embodiments, before the placenta is mixed with the first brown sugar for pickling, the following steps are also included: scalding the placenta with boiling water, chopping it into pieces, and then filtering it after boiling water.

[0019] The third object of the present invention is to provide the use of the pharmaceutical composition of the present application in promoting lactation and preventing mastitis in postpartum sows.

[0020] In some embodiments, the application method is to mix the pharmaceutical composition with feed and take it 1 to 2 times a day.

[0021] The present application provides a pharmaceutical composition, which utilizes the placenta in a reasonable combination with a variety of Chinese medicinal components and auxiliary materials, effectively utilizes the immune substances, proteins and other nutrients in the placenta, and enhances the functions and effects of nutrition by regulating the immunity of the pig body, tonifying the middle and replenishing qi, strengthening blood production, warming and nourishing the body, so that the body can produce active lactation ability and enhance immunity. In combination with Chinese medicinal components with similar functions and good palatability, the feeding efficiency of sows is improved, thereby achieving the dual effects of promoting lactation and preventing mastitis.

[0022] The preparation method of the pharmaceutical composition of the present application is simple and easy to operate, can be completed without the aid of large-scale equipment, and is economical and practical. In addition, during the preparation process, brown sugar is added twice to further improve the palatability of the pharmaceutical composition, thereby greatly improving the effectiveness of the pharmaceutical composition. DETAILED DESCRIPTION

[0023] References to embodiments of the present invention will now be provided in detail, one or more examples of which are described below. Each example is provided as an explanation rather than a limitation of the present invention. In fact, it will be apparent to those skilled in the art that various modifications and variations may be made to the present invention without departing from the scope or spirit of the present invention. For example, a feature illustrated or described as part of one embodiment may be used in another embodiment to produce a further embodiment.

[0024] Therefore, it is intended that the present invention covers such modifications and variations that fall within the scope of the appended claims and their equivalents. Other objects, features and aspects of the present invention are disclosed in or are obvious from the following detailed description. Those of ordinary skill in the art will appreciate that this discussion is only a description of exemplary embodiments and is not intended to limit the broader aspects of the present invention.

[0025] In the present invention, the technical features described in an open manner include closed technical solutions composed of the listed features, and also include open technical solutions containing the listed features.

[0026] In the present invention, when it comes to numerical ranges, unless otherwise specified, the above numerical ranges are deemed to be continuous and include the minimum and maximum values ​​of the range, as well as each value between such minimum and maximum values. Further, when a range refers to an integer, each integer between the minimum and maximum values ​​of the range is included. In addition, when multiple ranges are provided to describe features or characteristics, the ranges can be merged. In other words, unless otherwise specified, all ranges disclosed herein should be understood to include any and all subranges included therein.

[0027] In this article, when referring to the unit of a data range, if there is a unit only after the right endpoint, it means that the units of the left and right endpoints are the same. For example, 500-700g means that the units of the left endpoint "500" and the right endpoint "700" are both g (grams).

[0028] Since the beginning, the problem of sows having no milk, little milk, and mastitis after giving birth is a frequent but difficult to solve problem. At the same time, factors such as poor prenatal feeding and management of sows, excessive production consumption, and decreased feed intake after giving birth can all cause lactation disorders such as no lactation and little milk in sows after giving birth. Mastitis can also cause systemic infection or secondary infection of other diseases. These will lead to low survival rate or poor growth of piglets, thereby affecting the economic benefits of the farm.

[0029] At present, the methods used in the industry to solve the above problems are mainly simple Chinese medicine, Chinese patent medicine preparations or antibiotics for symptomatic treatment. Simple Chinese medicine or Chinese patent medicine preparations such as Cuiru Tang, Shenqi Tongru Tang, Cuiru San, etc. are limited by the fact that sows are not easy to accept their unique smell and poor palatability, resulting in insufficient intake of sows when eating, indirectly leading to poor efficacy and difficulty in achieving the expected effect. Antibiotics can only reduce inflammation and resist secondary infection, and basically have no effect on promoting lactation. There is also the problem of relatively high treatment costs.

[0030] In order to solve the above problems, the present invention provides a pharmaceutical composition on the one hand, which has the dual effects of promoting lactation for sows and preventing mastitis. In terms of weight, the pharmaceutical composition includes 14.9 to 42 parts of placenta, 2 to 4 parts of Chinese medicinal components and 8.9 to 15 parts of auxiliary materials. The placenta can be fresh pig placenta discharged by sows after farrowing, the Chinese medicinal components include astragalus, codonopsis, prepared rehmannia, pangolin, fenugreek, tongcao, motherwort and licorice, and the auxiliary materials include soybeans and brown sugar. The components in the pharmaceutical composition are common and easy to obtain, which reduces the production cost while having the dual effects of promoting lactation and preventing mastitis.

[0031] In some embodiments, the weight ratio of each component in the traditional Chinese medicine composition is (2-4): (2-4): (1.2-2.4): (2-4): (2-4): (1.2-2.4): (2-4): (1.2-2.4): (2-4): (1-2). For example, the weight ratio is 4:4:2.4:4:4:2.4:4:1; or 4:4:2.4:4:4:2.4:4:2; or 3:2:2:2:2:1.2:2:1; or 3:3:2:3:3:2:3:1.5. Preferably, the weight ratio is 2:2:1.2:2:2:1.2:2:1.2:2:1.

[0032] In some embodiments, the weight ratio of soybeans to brown sugar in the auxiliary materials is 1:(1-3), preferably 1:(1.5-2).

[0033] Placenta is the main drug of the pharmaceutical composition of this application. Studies have found that pig placenta contains a variety of active ingredients, among which the transfer factor contained can improve the phagocytic ability of leukocytes and the activity of superoxide dismutase of erythrocytes in peripheral blood, improve the body's immunity and antioxidant capacity, and can also regulate immune response and enhance lymphocyte proliferation. Therefore, it has excellent immunoregulation and the function of invigorating the middle and replenishing qi. In this application, the placenta is 14.9 to 42 parts by weight, including but not limited to 14.9 parts, 15 parts, 17 parts, 20.9 parts, 22.4 parts, 23 parts, 30 parts, 32 parts, 37 parts or 42 parts, and is not specifically limited.

[0034] Preferably, fresh pig placenta, i.e., healthy placenta discharged by sows after giving birth, is used in this application. Compared with the use of processed placenta, the use of fresh placenta can effectively reduce production costs while turning waste into treasure. In one course of treatment, the number of placentas is 2 to 4, and the weight of each placenta is 500 to 700 g.

[0035] Astragalus is sweet and warm in nature; it enters the spleen meridian and lung meridian. The Chinese Pharmacopoeia describes its main functions as: it has the effects of tonifying the spleen and replenishing qi, relieving stagnation and arthralgia, astringing sores and draining pus, nourishing blood and promoting muscle growth. It is suitable for diseases such as qi deficiency and fatigue, fatigue and poor appetite, sores, carbuncle, swelling, flesh disease and ulceration. The medicinal use of Astragalus has a history of more than 2,000 years. It has the effects of enhancing the body's immune function, protecting the liver, diuresis, anti-aging, anti-stress, lowering blood pressure and a wide range of antibacterial effects. In this application, by weight, Astragalus is 0.29 to 0.6 parts, including but not limited to 0.29 parts, 0.33 parts, 0.38 parts, 0.45 parts, 0.5 parts, 0.55 parts, and 0.6 parts, and is not specifically limited. By weight, Astragalus is 20 to 40g.

[0036] Codonopsis pilosula is sweet in taste and flat in nature. It is good at replenishing vital energy, promoting body fluid and quenching thirst. It is an important compatibility of sweet and warm qi-tonifying. It is suitable for various symptoms of physical weakness such as fatigue, poor appetite, spontaneous sweating caused by qi deficiency. It can also be used for symptoms such as qi and blood deficiency and blood deficiency. In this application, by weight, Codonopsis pilosula is 0.29-0.6 parts, including but not limited to 0.29 parts, 0.33 parts, 0.38 parts, 0.45 parts, 0.5 parts, 0.55 parts, and 0.6 parts, which are not specifically limited. By weight, Codonopsis pilosula is 20-40g.

[0037] Rehmannia glutinosa is sweet and moist, with a slightly warm nature. It has the effects of replenishing essence and marrow, nourishing blood and yin, nourishing blood and replenishing deficiency. It can be used in combination with placenta, Codonopsis pilosula, Astragalus membranaceus, etc. to treat symptoms caused by postpartum yin deficiency and blood loss. In this application, by weight, Rehmannia glutinosa is 0.17 to 0.36 parts, including but not limited to 0.17 parts, 0.2 parts, 0.23 parts, 0.27 parts, 0.3 parts, 0.33 parts, and 0.36 parts, and is not specifically limited. By weight, Rehmannia glutinosa is 12 to 24g.

[0038] Pangolin tastes salty and is slightly cold in nature; it enters the liver and stomach meridians. Main functions: promoting blood circulation and eliminating phlegm, promoting menstruation and promoting lactation, reducing swelling and draining pus. It is suitable for postpartum mastitis, milk retention, mastitis, endometritis and other inflammatory infections when used in combination with astragalus. In this application, the pangolin is 0.29 to 0.6 parts by weight, including but not limited to 0.29 parts, 0.33 parts, 0.38 parts, 0.45 parts, 0.5 parts, 0.55 parts, and 0.6 parts, and is not specifically limited. By weight, the pangolin is 20 to 40g.

[0039] Wangbuliuxing is bitter and flat in nature; it enters the liver and stomach meridians, and its main functions are: promoting blood circulation and menstruation, promoting lactation and reducing swelling, and promoting diuresis and relieving stranguria. Among them, the prescription group compatibility used for promoting menstruation and lactation, scarce milk, poor milk discharge, and mastitis and swelling is very suitable; at the same time, it has the effects of promoting blood circulation and reducing swelling, removing blood stasis, reducing lumps and swelling and poison in sores, and has anti-inflammatory effects. For postpartum mastitis and endometritis, it can also play an anti-inflammatory, swelling-dispersing, and analgesic role. In this application, by weight, Wangbuliuxing is 0.29 to 0.6 parts, including but not limited to 0.29 parts, 0.33 parts, 0.38 parts, 0.45 parts, 0.5 parts, 0.55 parts, and 0.6 parts, and is not specifically limited. By weight, Wangbuliuxing is 20 to 40g.

[0040] Tongcao is cold in nature and tastes sweet and light. Main functions: used for ventilation, lactation, clearing heat and diuresis. If postpartum milk is blocked, milk is too little, or mastitis occurs, Tongcao can be used in combination, and the effect is also very good. In this application, Tongcao is 0.17 to 0.36 parts by weight, including but not limited to 0.17 parts, 0.2 parts, 0.23 parts, 0.27 parts, 0.3 parts, 0.33 parts, and 0.36 parts, and is not specifically limited. By weight, Tongcao is 12 to 24g.

[0041] Motherwort tastes bitter and pungent, and is slightly cold in nature; it enters the pericardium and liver meridians. Main functions: promoting blood circulation and removing blood stasis, regulating menstruation and promoting diuresis, treating persistent lochia, sores and swelling; it has good efficacy in treating dystocia in sows, retained placenta, persistent blood stasis, mastitis, and endometritis. In this application, by weight, the motherwort is 0.29 to 0.6 parts, including but not limited to 0.29 parts, 0.33 parts, 0.38 parts, 0.45 parts, 0.5 parts, 0.55 parts, and 0.6 parts, and is not specifically limited. By weight, the motherwort is 20 to 40g.

[0042] Licorice is sweet and warm in nature; it enters the stomach, lung, and spleen meridians. Main functions: clearing away heat and detoxifying, moistening the lungs and relieving cough, harmonizing various medicines, and detoxifying hundreds of medicines. In this application, by weight, licorice is 0.14 to 0.3 parts, including but not limited to 0.14 parts, 0.18 parts, 0.2 parts, 0.22 parts, 0.25 parts, 0.28 parts, and 0.3 parts, and is not specifically limited. By weight, licorice is 10 to 20g.

[0043] Soybean has the effects of strengthening the spleen and stomach, regulating gastrointestinal function, and is rich in soy oligosaccharides, which can promote the growth of bifidobacteria, thereby helping to inhibit the growth of harmful flora in the intestine. In addition, soy is rich in plant protein, dietary fiber and soy lecithin, which can enhance the body's immunity and resistance, and provide nutrients such as protein, vitamins, dietary fiber and other nutrients required by the body. Thus, the use of soy in combination can increase the lactation of sows. In this application, by weight, soy is 2.9 to 6 parts, including but not limited to 2.9 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts, 5 parts, and 6 parts, and is not specifically limited. By weight, soy is 200 to 400g.

[0044] Brown sugar is sweet and warm in nature. It has the effects of nourishing qi and blood, dispelling cold and activating blood circulation, strengthening the spleen and warming the stomach. It is suitable for sows with postpartum qi and blood deficiency, fatigue, weakness, loss of appetite and other symptoms; brown sugar can also directly provide energy to the body, and has a good effect on sows with postpartum physical weakness and lack of milk, and regulating the palatability of the prescription group. In this application, by weight, brown sugar is 5.9 to 9 parts, including but not limited to 5.9 parts, 6 parts, 6.5 parts, 7 parts, 7.5 parts, 8 parts, and 9 parts, without specific limitation. By weight, brown sugar is 400 to 600g.

[0045] In some embodiments, the dosage form of the pharmaceutical composition can be one of granules, tablets, capsules, pills, powders and lozenges, preferably powders.

[0046] The pharmaceutical composition of the present application is to organically match the placenta with specific Chinese medicine components and auxiliary materials, effectively utilize the immune substances, proteins and other nutrients in the pig placenta, and regulate the immune system of the pig body, invigorate the middle and replenish qi, strengthen blood production, warm and replenish the body to enhance the function and effect of nutrition, so that the body can produce active lactation ability and improve immunity, and then cooperate with a combination of Chinese medicines with similar functions and good palatability to improve the feeding efficiency of sows, so as to achieve the effects of rapid recovery of physical strength, lactation, heat-clearing and anti-inflammatory, suppuration and muscle regeneration. At the same time, the Chinese medicine components in the pharmaceutical composition of the present application mostly use sweet ingredients such as astragalus, reduce the introduction amount of medicinal materials containing special smells without affecting the therapeutic effect, improve the palatability of the pharmaceutical composition of the present application, and then improve the intake of sows when eating, maximize the use of the active ingredients of various Chinese medicines, and further ensure the therapeutic effect.

[0047] The second aspect of the present application provides a method for preparing the pharmaceutical composition, comprising the following steps:

[0048] S1: soaking soybeans to obtain a mixture;

[0049] S2: soaking the Chinese medicinal components, boiling and filtering to obtain a first filter residue and a first filtrate;

[0050] S3: mixing and marinating the placenta with the first brown sugar, and then boiling and filtering the mixture to obtain a second residue and a second filtrate;

[0051] S4: mixing the second filter residue with the Codonopsis pilosula, Rehmannia glutinosa and Licorice root in the first filter residue and beating the mixture to obtain a slurry;

[0052] S5: stirring the first filtrate, the second filtrate and the second brown sugar to obtain a mixed solution; and

[0053] S6: Mix the slurry with the mixed solution to obtain a pharmaceutical composition.

[0054] The mixture contains soybeans and water for soaking soybeans. The first filter residue is the residue of Chinese medicinal components, including astragalus, codonopsis, rehmannia, pangolin, fenugreek, tongcao, motherwort and liquorice; the first filtrate is the Chinese medicinal water obtained by boiling the Chinese medicinal components. The second filter residue contains solid substances of placenta and soybeans; the slurry contains solid substances of placenta, soybeans, codonopsis, rehmannia and liquorice.

[0055] On the one hand, the preparation method of the present application is simple and easy to operate, and the main drug can use the healthy placenta after sow delivery, which effectively reduces the production cost while taking local materials and turning waste into treasure, and is economical and practical for farms. On the other hand, the step of pickling the placenta with brown sugar effectively improves the palatability of the pharmaceutical composition and can also improve the efficacy.

[0056] In some embodiments, the preparation method of the present application may further include the step of frying raw soybeans before S1, utilizing the principle that high temperature destroys soybean anti-trypsin and high temperature ripening changes the odor, thereby improving the palatability of the drug composition and promoting the digestion and absorption capacity of sows.

[0057] In some embodiments, a proportional weighing step is also included before S1 and S2. After the weighing is completed, the soybeans are soaked in 2 kg of water for 1 to 2 hours, and the Chinese medicine components are also soaked in 2 kg of water for 1 to 2 hours, so that the active ingredients of the medicine are better dissolved into the aqueous solution.

[0058] In some embodiments, the boiling step in S2 is specifically to put the soaked Chinese medicinal components and the water in which the Chinese medicinal components are soaked into a stew pot, boil them over medium heat until boiling, then boil them over low heat for 30 minutes, filter them, and cool the first medicinal liquid for later use. The filtered medicinal residue is soaked again in 2 kg of water for 1 to 2 hours, and the boiling and filtering steps are repeated to obtain the second medicinal liquid. The third medicinal liquid and the first filter residue are obtained by the same method, and the first medicinal liquid, the second medicinal liquid, and the third medicinal liquid are mixed to obtain the first filtrate.

[0059] The Codonopsis pilosula, Rehmannia glutinosa and Licorice root in the first filtration residue are picked out and used in S4.

[0060] In some embodiments, the placenta is repeatedly washed with clean water before pickling in S3, and then scalded with boiling water for 3 to 5 minutes to remove the fishy smell, and then chopped into block-shaped placenta particles and boiled in boiling water again to remove the fishy smell, and then brown sugar is added to the block-shaped placenta particles for pickling.

[0061] The cooking step in S3 can be completed in a household stew pot. Put the marinated placenta particles, soybeans and the water used to soak the soybeans into the stew pot, cook over medium heat until boiling, then simmer over low heat for 30 minutes.

[0062] The second filter residue and the second filtrate obtained by filtering in S3 are cooled and then used for later use.

[0063] Optionally, the pickling time is 20 to 40 minutes, preferably 30 minutes. The placenta is pickled with brown sugar and then boiled, which helps to improve its taste and improve the palatability of the pharmaceutical composition without affecting the efficacy.

[0064] In some embodiments, the beating in step S4 can be performed using a household meat grinder, which is economical and practical while being easy to operate.

[0065] In some embodiments, the first brown sugar in S3 and the second brown sugar in S5 have the same weight.

[0066] In some embodiments, after the slurry and the mixed liquid are mixed in S6, they are stirred to obtain a uniformly mixed pharmaceutical composition, which can be placed in a freezer for storage.

[0067] Preferably, before transferring the pharmaceutical composition to the freezer, it is evenly divided into 3 to 6 portions for subsequent feeding to sows.

[0068] The third object of the present invention is to provide the use of the pharmaceutical composition of the present application in promoting lactation and preventing mastitis in postpartum sows.

[0069] In some embodiments, the application method is to mix the pharmaceutical composition with feed and take it 1 to 2 times a day, and 3 consecutive days is a course of treatment. According to the health status of the sow, 1 to 3 courses of treatment can be used. Preferably, 2 to 3 courses of treatment are used.

[0070] Example 1

[0071] This embodiment provides a pharmaceutical composition having the dual effects of promoting lactation and preventing mastitis, which is composed of the following components:

[0072] 2 fresh placentas, each weighing about 500g; 20g Astragalus, 20g Codonopsis, 12g Rehmannia, 20g Pangolin, 20g Vaccaria, 12g Tongcao, 20g Leonurus, 10g Licorice; 200g soybeans, 400g brown sugar.

[0073] After the pharmaceutical composition is prepared by the method described above, it is divided into 6 portions and administered for 3 days, twice a day. During each administration, the pharmaceutical composition is taken out of the freezer and mixed evenly with the feed. The following examples and comparative examples adopt the same administration method.

[0074] Example 2

[0075] This embodiment provides a pharmaceutical composition having the dual effects of promoting lactation and preventing mastitis, which is composed of the following components:

[0076] 2 fresh placentas, each weighing about 500g; 30g Astragalus, 30g Codonopsis, 18g Rehmannia, 30g Pangolin, 30g Vaccaria, 18g Tongcao, 30g Leonurus, 15g Licorice; 300g soybeans, 500g brown sugar.

[0077] Example 3

[0078] This embodiment provides a pharmaceutical composition having the dual effects of promoting lactation and preventing mastitis, which is composed of the following components:

[0079] 2 fresh placentas, each weighing about 500g; 40g Astragalus, 40g Codonopsis, 24g Rehmannia, 40g Pangolin, 40g Vaccaria, 24g Tongcao, 40g Leonurus, 10g Licorice; 400g soybeans, 600g brown sugar.

[0080] Example 4

[0081] This embodiment provides a pharmaceutical composition having the dual effects of promoting lactation and preventing mastitis, which is composed of the following components:

[0082] 4 fresh placentas, each weighing about 700g; 40g Astragalus, 40g Codonopsis, 24g Rehmannia, 40g Pangolin, 40g Vaccaria, 24g Tongcao, 40g Leonurus, 10g Licorice; 400g soybeans, 600g brown sugar.

[0083] Comparative Example 1

[0084] This comparative example adopts a commercially available milk-clearing granule, which is composed of the following components:

[0085] 50g of Akebia, 50g of Red Peony Root, 50g of Radix Trichosanthis, 50g of Angelica Dahurica, 50g of Glehnia littoralis, 50g of Platycodon grandiflorum, 50g of Forsythia suspensa, 10g of Licorice, 20g of Dianthus superbus, and 20g of Citrus aurantium.

[0086] Comparative Example 2

[0087] This comparative example provides a pharmaceutical composition having the dual effects of promoting lactation and preventing mastitis. The pharmaceutical components in this comparative example are similar to those in Example 2, except that: no fresh placenta is added to the pharmaceutical composition in this comparative example.

[0088] Comparative Example 3

[0089] This comparative example provides a pharmaceutical composition having the dual effects of promoting lactation and preventing mastitis. The pharmaceutical components in this comparative example are similar to those in Example 2, except that brown sugar is not added to the pharmaceutical composition in this comparative example.

[0090] Comparative Example 4

[0091] This comparative example provides a pharmaceutical composition having the dual effects of promoting lactation and preventing mastitis, which is composed of the following components:

[0092] 5 fresh placentas, each weighing about 700g; 30g Astragalus, 30g Codonopsis, 18g Rehmannia, 30g Pangolin, 30g Vaccaria, 18g Tongcao, 30g Leonurus, 15g Licorice; 300g soybeans, 500g brown sugar.

[0093] Comparative Example 5

[0094] This comparative example provides a pharmaceutical composition having the dual effects of promoting lactation and preventing mastitis, which is composed of the following components:

[0095] 2 fresh placentas, each weighing about 500g; 30g Astragalus, 30g Codonopsis, 18g Rehmannia, 30g Pangolin, 30g Vaccaria, 18g Tongcao, 30g Leonurus, 15g Licorice; 300g soybeans, 800g brown sugar.

[0096] Comparative Example 6

[0097] This comparative example provides a pharmaceutical composition having the dual effects of promoting lactation and preventing mastitis, which is composed of the following components:

[0098] 2 fresh placentas, each weighing about 500g; 30g Astragalus, 30g Codonopsis, 20g Rehmannia, 30g Pangolin, 30g Vaccaria, 10g Tongcao, 30g Leonurus, 8g Licorice; 300g soybeans, 500g brown sugar.

[0099] Experimental example

[0100] The above-mentioned Examples 1 to 4 and Comparative Examples 1 to 3 were subjected to effect verification experiments. 35 sows and their piglets were selected after farrowing, and their weights were recorded respectively. The sows were divided into 7 groups, 5 in each group, and applied to Examples 1 to 4 and Comparative Examples 1 to 3 respectively. When feeding, the drug composition was mixed with the feed, stirred evenly, and fed 1 to 2 times a day for 6 consecutive days. Data statistics were performed during the period, and the specific data are summarized as follows.

[0101] 1. Study on the palatability effect of the drug composition by sow intake

[0102] The intake refers to the weight of the pharmaceutical composition ingested by each sow per day on average, and the D1 intake is the weight of the pharmaceutical composition ingested by each sow per day on the first day on average. First, the pharmaceutical composition and feed are weighed to obtain the weight of the pharmaceutical composition and the weight of the feed, and then the two are mixed and stirred evenly and fed to the sows. Finally, after the sows finish eating, they are weighed again to obtain the remaining total amount, thereby calculating the single-day intake = (weight of the pharmaceutical composition + weight of the feed - total remaining amount) * weight of the pharmaceutical composition / (weight of the pharmaceutical composition + weight of the feed).

[0103] The intake on days 1, 2, 4, and 6 was monitored, and the average daily drug intake per sow was calculated based on the 4-day intake. The data are summarized in Table 1 below.

[0104] Table 1 shows the effect of the drug composition on the intake of sows

[0105]

[0106] It can be seen from the data in Table 1 that the intake of Examples 1 to 4 and Comparative Example 2 is higher than that of Comparative Example 1, indicating that the palatability of the pharmaceutical composition of the present application is improved; the intake of Comparative Example 3 is lower than that of Examples 1 to 4 and higher than that of Comparative Example 1, indicating that the addition of brown sugar helps to improve the palatability of the pharmaceutical composition; the intake of Comparative Examples 4 and 6 is significantly lower than that of Examples 1 to 4, indicating that increasing the amount of placenta or changing the drug formulation significantly reduces the food intake; the intake of Comparative Example 5 is lower than that of Examples 1 to 4, indicating that excessive addition of brown sugar will affect the palatability of the pharmaceutical composition.

[0107] 2. Detecting the effect of the drug composition on sow lactation by changes in piglet weight

[0108] The lactation amount is calculated by the difference in weight of the entire litter of piglets before and after lactation. Taking the lactation amount of D1 as an example, the weight of the piglets in each litter is weighed at 6 o'clock in the morning before medication, and weighed again at 6 o'clock in the morning of the next day after one day of medication and feeding. The difference between the two is the lactation amount of each sow. The average lactation amount of 5 sows is the lactation amount of D1.

[0109] The lactation amount of the sows was measured before administration as D0 lactation amount, and the lactation amount was monitored on days 1, 2, 3, and 6 after administration. The data are summarized in Table 2 below.

[0110] Table 2 shows the effects of different drug combinations on sow lactation

[0111]

[0112] From the data in the table, it can be seen that the lactation amount of Examples 1 to 4 is higher than that of Comparative Examples 1 to 4 and Comparative Example 6, which shows that the pharmaceutical composition of the present application has a good lactation-promoting effect.

[0113] 3. Efficacy of the pharmaceutical composition on mastitis

[0114] Case A total of 100 multiparous sows diagnosed with mastitis were randomly selected and evenly divided into 10 groups, each with 10 sows, and applied to Examples 1 to 4 and Comparative Examples 1 to 6, respectively. The pharmaceutical composition was mixed with the feed and stirred evenly during feeding, 1 to 2 times a day, and fed continuously for 6 days. After the test, the feeding situation was observed according to the following judgment criteria, and corresponding records were made, and the data were collected in Table 3.

[0115] Recovery: After 6 days of feeding, the redness and swelling of the pig's breasts subsided, and its spirit and appetite returned to normal;

[0116] Improvement: After 6 days of feeding, the redness, swelling, heat and pain in the udder of the affected pigs basically disappeared, and their spirits and appetite returned to normal;

[0117] Ineffective: After 6 days of feeding, the udder symptoms of the affected pigs did not improve or became more severe.

[0118] Table 3 is the statistical results of the efficacy of different drug combinations on sow mastitis

[0119] get well Improvement invalid Recovery rate / % Example 1 6 4 0 60% Example 2 7 3 0 70% Example 3 8 2 0 80% Example 4 6 4 0 60% Comparative Example 1 0 0 10 0% Comparative Example 2 2 3 5 20% Comparative Example 3 3 4 3 30% Comparative Example 4 3 4 3 30% Comparative Example 5 6 4 0 60% Comparative Example 6 2 3 5 20%

[0120] It can be seen from the efficacy results in Table 3 that after the sows were fed with the pharmaceutical compositions of Examples 1 to 4 for 6 days, they all achieved certain efficacy, and there was no ineffectiveness; Comparative Example 1 did not have the function of preventing and treating sow mastitis, and all showed ineffectiveness; Comparative Examples 2 to 4 and 6 all showed improvement, but the effect was worse than that of Examples 1 to 4. It can be seen that the sow feed of the present application has a good preventive and therapeutic effect on preventing and treating sow mastitis.

[0121] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0122] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.

Claims

1. A pharmaceutical composition for promoting lactation and preventing mastitis in postpartum sows, characterized in that: In parts by weight, the pharmaceutical composition consists of 14.9 to 42 parts of placenta, 2 to 4 parts of traditional Chinese medicine components and 8.9 to 15 parts of auxiliary materials; The Chinese medicinal components are composed of astragalus, codonopsis, rehmannia, pangolin, fenugreek, tongcao, motherwort and liquorice; The auxiliary materials consist of soybeans and brown sugar; The weight ratio of each component in the traditional Chinese medicine composition is astragalus: codonopsis: rehmannia: pangolin: fenugreek: tongcao: motherwort: liquorice is (2-4): (2-4): (1.2-2.4): (2-4): (2-4): (1.2-2.4): (2-4): (1.2-2.4): (2-4): (1-2); The weight ratio of soybean to brown sugar in the auxiliary material is 1:(1-3); The placenta is a pig placenta.

2. A method for preparing the pharmaceutical composition according to claim 1, characterized in that: The following steps are involved: Soak soybeans to obtain a mixture; After soaking the Chinese medicinal components, boiling and filtering to obtain a first filter residue and a first filtrate; The placenta is mixed with the first brown sugar and marinated, and then boiled with the mixture and filtered to obtain a second residue and a second filtrate; The second filter residue is mixed with the codonopsis pilosula, rehmannia glutinosa and liquorice in the first filter residue to obtain a slurry; The first filtrate, the second filtrate and the second brown sugar are stirred to obtain a mixed liquid; as well as The slurry is mixed with the mixed solution to obtain the pharmaceutical composition.

3. The preparation method according to claim 2, characterized in that: The soybeans are fried and then soaked.

4. The preparation method according to claim 2, characterized in that: The weight of the first brown sugar is consistent with that of the second brown sugar.

5. The preparation method according to claim 2, characterized in that: Before the placenta is mixed with the first brown sugar and marinated, The method comprises the following steps: scalding the placenta with boiling water, chopping the placenta into pieces, and filtering the placenta with boiling water.

6. Use of the pharmaceutical composition according to claim 1 in preparing drugs for promoting lactation and preventing mastitis in postpartum sows.